Literature DB >> 22381466

Expression and purification of recombinant protein related to DAN and cerberus (PRDC).

Chandramohan Kattamuri1, David M Luedeke, Thomas B Thompson.   

Abstract

Bone morphogenetic proteins (<span class="Gene">BMPs) are secreted protein ligands that control numerous biological processes, such as cell differentiation and cell proliferation. Ligands are regulated by a large number of structurally diverse extracellular antagonists. PRDC or protein related to DAN and cerberus is a BMP antagonist of the DAN family, which is defined by a conserved pattern of cysteine residues that form a ring structure. Here we present the expression and purification of recombinant mouse PRDC (mPRDC) from bacterial (Escherichia coli) inclusion bodies through oxidative refolding. Functional mPRDC was isolated from a nonfunctional component through reverse phase chromatography and shown to inhibit BMP2 and BMP4 in a cell-based luciferase reporter assay. Recombinant mPRDC also bound directly to BMP2, BMP4 and BMP7, but not activin A. Furthermore, circular dichroism indicated that mPRDC is folded and contains a higher than anticipated helical content for a DAN family member protein.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381466      PMCID: PMC3319168          DOI: 10.1016/j.pep.2012.02.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  43 in total

1.  Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin.

Authors:  O Hashimoto; N Kawasaki; K Tsuchida; S Shimasaki; T Hayakawa; H Sugino
Journal:  Cell Signal       Date:  2000-08       Impact factor: 4.315

Review 2.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data.

Authors:  Lee Whitmore; B A Wallace
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

Review 5.  Bone morphogenetic proteins in development.

Authors:  B L Hogan
Journal:  Curr Opin Genet Dev       Date:  1996-08       Impact factor: 5.578

6.  A method for the complete S sulfonation of cysteine residues in proteins.

Authors:  W W Chan
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

Review 7.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

8.  Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.

Authors:  Naoki Kusu; Johanna Laurikkala; Mayumi Imanishi; Hiroko Usui; Morichika Konishi; Ayumi Miyake; Irma Thesleff; Nobuyuki Itoh
Journal:  J Biol Chem       Date:  2003-04-17       Impact factor: 5.157

Review 9.  TGF-beta-receptor-mediated signaling.

Authors:  R Derynck
Journal:  Trends Biochem Sci       Date:  1994-12       Impact factor: 13.807

10.  A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum.

Authors:  Blanca Herrera; Gareth J Inman
Journal:  BMC Cell Biol       Date:  2009-03-19       Impact factor: 4.241

View more
  8 in total

1.  Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.

Authors:  Kristof Nolan; Chandramohan Kattamuri; David M Luedeke; Elizabeth B Angerman; Scott A Rankin; Mariana L Stevens; Aaron M Zorn; Thomas B Thompson
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

2.  Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2.

Authors:  Jeffery B Bylund; Antonis K Hatzopoulos
Journal:  J Vis Exp       Date:  2016-03-10       Impact factor: 1.355

3.  Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.

Authors:  Chandramohan Kattamuri; Kristof Nolan; Thomas B Thompson
Journal:  Biochem J       Date:  2017-03-08       Impact factor: 3.857

4.  Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism.

Authors:  Kristof Nolan; Chandramohan Kattamuri; David M Luedeke; Xiaodi Deng; Amrita Jagpal; Fuming Zhang; Robert J Linhardt; Alan P Kenny; Aaron M Zorn; Thomas B Thompson
Journal:  Structure       Date:  2013-07-11       Impact factor: 5.006

5.  Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.

Authors:  Jeffery B Bylund; Linh T Trinh; Cassandra P Awgulewitsch; David T Paik; Christopher Jetter; Rajneesh Jha; Jianhua Zhang; Kristof Nolan; Chunhui Xu; Thomas B Thompson; Timothy J Kamp; Antonis K Hatzopoulos
Journal:  Stem Cells Dev       Date:  2017-03-20       Impact factor: 3.272

Review 6.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

7.  Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers.

Authors:  Chandramohan Kattamuri; David M Luedeke; Kristof Nolan; Scott A Rankin; Kenneth D Greis; Aaron M Zorn; Thomas B Thompson
Journal:  J Mol Biol       Date:  2012-10-09       Impact factor: 5.469

8.  Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST.

Authors:  Gregory R Gipson; Chandramohan Kattamuri; Magdalena Czepnik; Thomas B Thompson
Journal:  Biochem J       Date:  2020-09-18       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.